Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Alert

Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

April 24, 2020

COVID-19: Additional Funds Authorized for Small Business Relief

In response to the Paycheck Protection Program running out of funding earlier this month, the Paycheck Protection Program and Health Care Enhancement Act was signed into law today. To increase amounts authorized and appropriated for the Paycheck Protection Program; economic injury disaster loans (EIDLs); emergency grants; and further funding for hospitals, providers, and testing, the Enhancement Act adds approximately $484 billion to COVID-19 relief.

Specifically with respect to the Paycheck Protection Program, the initial $349 billion set aside for small business loans has been increased to $659 billion. The eligibility and affiliation rules and the calculation of the maximum loan amount promulgated under the CARES Act and its subsequent guidance remain unchanged. The Enhancement Act also doubles the funds available to borrowers through emergency EIDL grants from $10 billion to $20 billion and provides an additional $50 billion for EIDLs.

New under the Enhancement Act is the requirement that funds are set aside for smaller and minority-owned insured depository institutions, credit unions, and community development financial institutions to ensure that businesses have access to loans from lenders of all sizes. Specifically, not less than $30 billion of the newly deployed funds are to be used for loans made by insured depository institutions and credit unions with between $10 billion and $50 billion in consolidated assets. An additional $30 billion has been set aside to ensure loans are made by a combination of community financial institutions, insured depository institutions, and credit unions with less than $10 billion in consolidated assets.

If you have any questions regarding the content of this alert, please contact Roger Cominsky, Financial Institutions & Lending Practice Area chair, at rcominsky@barclaydamon.com ; Danielle Katz, associate, at dkatz@barclaydamon.com ; or another member of the firm’s Financial Institutions & Lending Practice Area.

We also have a specific team of Barclay Damon attorneys who are actively working on assessing regulatory, legislative, and other governmental updates related to COVID-19 and who are prepared to assist clients. You can reach our COVID-19 Response Team at COVID-19ResponseTeam@barclaydamon.com.

Featured Media

Alerts

Second Department Joins Other Departments: NYS Child Victims Act Applies to Out-of-State Residents Who Resided in NYS at Time of Abuse

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Gladys Vasquez, Monique Reid, Raymond Forrest, Pedro Martinez, Linda Slade, and Felipe Fernandez—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Compres, Sanchez, Fontanez, Pajaro, Garcia, and Jaquez—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Competello, Fernandez, Liz, Riley, and Trippett—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

CDPAP Providers Get First Look at the Future of CDPAP Without FIs

Alerts

New York State Fiscal Year 2025 Budget: Implications for Employers Unpacked

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out